These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32825941)

  • 1. The expression of calpain-1 and androgen receptor in breast cancer and their correlation with clinicopathological characteristics: An immunohistochemical retrospective study.
    Rajković-Molek K; Mustać E; Avirović M; Georgev P; Demaria M; Aničić J; Ban J; Babarović E
    Pathol Res Pract; 2020 Sep; 216(9):153068. PubMed ID: 32825941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor expression in a Sri Lankan patient cohort with early breast carcinoma.
    Wijesinghe HD; Wijesinghe GK; Mansoor Z; Vigneshwara S; Fernando J; Gunasekera D; Lokuhetty MDS
    BMC Womens Health; 2020 Sep; 20(1):206. PubMed ID: 32928183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer.
    Tokunaga E; Hisamatsu Y; Taketani K; Yamashita N; Akiyoshi S; Okada S; Tanaka K; Saeki H; Oki E; Aishima S; Oda Y; Morita M; Maehara Y
    Cancer Med; 2013 Dec; 2(6):763-73. PubMed ID: 24403250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does androgen receptor have a prognostic role in patients with estrogen/progesterone-negative and c-erbB-2-positive breast cancer?
    Arslan C; Isik M; Guler G; Kulac I; Solak M; Turker B; Ozisik Y; Altundag K
    Am Surg; 2012 Sep; 78(9):992-9. PubMed ID: 22964210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of androgen receptors in primary breast cancer.
    Park S; Koo J; Park HS; Kim JH; Choi SY; Lee JH; Park BW; Lee KS
    Ann Oncol; 2010 Mar; 21(3):488-492. PubMed ID: 19887463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer.
    Tang D; Xu S; Zhang Q; Zhao W
    Med Oncol; 2012 Jun; 29(2):526-33. PubMed ID: 21519872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of androgen receptor and its phosphorylated forms in breast cancer progression.
    Ren Q; Zhang L; Ruoff R; Ha S; Wang J; Jain S; Reuter V; Gerald W; Giri DD; Melamed J; Garabedian MJ; Lee P; Logan SK
    Cancer; 2013 Jul; 119(14):2532-40. PubMed ID: 23605249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calpain system protein expression in basal-like and triple-negative invasive breast cancer.
    Storr SJ; Lee KW; Woolston CM; Safuan S; Green AR; Macmillan RD; Benhasouna A; Parr T; Ellis IO; Martin SG
    Ann Oncol; 2012 Sep; 23(9):2289-2296. PubMed ID: 22745213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of androgen receptor in primary breast carcinoma and its relation with clinicopathologic features, estrogen, progesterone, and her-2 receptor status.
    Vellaisamy G; Tirumalae R; Inchara YK
    J Cancer Res Ther; 2019; 15(5):989-993. PubMed ID: 31603099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor expression shows distinctive significance in ER positive and negative breast cancers.
    Tsang JY; Ni YB; Chan SK; Shao MM; Law BK; Tan PH; Tse GM
    Ann Surg Oncol; 2014 Jul; 21(7):2218-28. PubMed ID: 24639191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtype classification for prediction of prognosis of breast cancer from a biomarker panel: correlations and indications.
    Chen C; Yuan JP; Wei W; Tu Y; Yao F; Yang XQ; Sun JZ; Sun SR; Li Y
    Int J Nanomedicine; 2014; 9():1039-48. PubMed ID: 24591826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers.
    Park S; Koo JS; Kim MS; Park HS; Lee JS; Lee JS; Kim SI; Park BW; Lee KS
    Ann Oncol; 2011 Aug; 22(8):1755-62. PubMed ID: 21310761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status.
    Jiang HS; Kuang XY; Sun WL; Xu Y; Zheng YZ; Liu YR; Lang GT; Qiao F; Hu X; Shao ZM
    Oncotarget; 2016 Jul; 7(27):41285-41293. PubMed ID: 27285752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor-expressing triple-negative breast carcinoma.
    Sutton LM; Cao D; Sarode V; Molberg KH; Torgbe K; Haley B; Peng Y
    Am J Clin Pathol; 2012 Oct; 138(4):511-6. PubMed ID: 23010705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor expression inversely correlates with histological grade and N stage in ER
    Scatena C; Scarpitta R; Innocenti L; Miccoli M; Biancotti R; Diodati L; Ghilli M; Naccarato AG
    Breast Cancer Res Treat; 2020 Jul; 182(1):55-65. PubMed ID: 32436149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.
    Vera-Badillo FE; Templeton AJ; de Gouveia P; Diaz-Padilla I; Bedard PL; Al-Mubarak M; Seruga B; Tannock IF; Ocana A; Amir E
    J Natl Cancer Inst; 2014 Jan; 106(1):djt319. PubMed ID: 24273215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical significance of androgen receptor in triple negative breast cancer.
    Luo X; Shi YX; Li ZM; Jiang WQ
    Chin J Cancer; 2010 Jun; 29(6):585-90. PubMed ID: 20507730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status.
    Zhang X; Eliassen AH; Tamimi RM; Hazra A; Beck AH; Brown M; Collins LC; Rosner B; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):962-8. PubMed ID: 25855627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray.
    He J; Peng R; Yuan Z; Wang S; Peng J; Lin G; Jiang X; Qin T
    Med Oncol; 2012 Jun; 29(2):406-10. PubMed ID: 21264529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.